Search research articles
Contact Us
Filters
Showing results (291-300 of 845) with videos related to
Page
of 85
Sort By:
The Journal of Urology
|
February 14, 2014
Re: aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial
Samir S Taneja
The Journal of Urology
|
February 14, 2014
Re: docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial
Samir S Taneja
The Journal of Urology
|
November 11, 2018
Re: Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer
Samir S Taneja
The Journal of Urology
|
February 18, 2017
Re: Quantified Clinical Risk Change as an End Point during Prostate Cancer Active Surveillance
Samir S Taneja
The Journal of Urology
|
October 27, 2018
Re: Circulating microRNAs and Treatment Response in the Phase II SWOG S0925 Study for Patients with New Metastatic Hormone-Sensitive Prostate Cancer
Samir S Taneja
The Journal of Urology
|
January 18, 2017
Re: Magnetic Resonance Imaging-Ultrasound Fusion Biopsy during Prostate Cancer Active Surveillance
Samir S Taneja
The Journal of Urology
|
July 12, 2019
Re: Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
Samir S Taneja
The Journal of Urology
|
July 12, 2019
Re: Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
Samir S Taneja
The Journal of Urology
|
April 16, 2020
Re: Lifetime Benefits and Harms of PSA-Based Risk Screening for Prostate Cancer
Samir S Taneja
The Journal of Urology
|
April 20, 2015
Re: Does discontinuous involvement of a prostatic needle biopsy core by adenocarcinoma correlate with a large tumor focus at radical prostatectomy?
Samir S Taneja
Page
of 85
Search research articles
Search
Showing results (291-300 of 845) with videos related to
Sort By:
Page
of 85
The Journal of Urology
|
February 14, 2014
Re: aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial
Samir S Taneja
The Journal of Urology
|
February 14, 2014
Re: docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial
Samir S Taneja
The Journal of Urology
|
November 11, 2018
Re: Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer
Samir S Taneja
The Journal of Urology
|
February 18, 2017
Re: Quantified Clinical Risk Change as an End Point during Prostate Cancer Active Surveillance
Samir S Taneja
The Journal of Urology
|
October 27, 2018
Re: Circulating microRNAs and Treatment Response in the Phase II SWOG S0925 Study for Patients with New Metastatic Hormone-Sensitive Prostate Cancer
Samir S Taneja
The Journal of Urology
|
January 18, 2017
Re: Magnetic Resonance Imaging-Ultrasound Fusion Biopsy during Prostate Cancer Active Surveillance
Samir S Taneja
The Journal of Urology
|
July 12, 2019
Re: Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
Samir S Taneja
The Journal of Urology
|
July 12, 2019
Re: Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
Samir S Taneja
The Journal of Urology
|
April 16, 2020
Re: Lifetime Benefits and Harms of PSA-Based Risk Screening for Prostate Cancer
Samir S Taneja
The Journal of Urology
|
April 20, 2015
Re: Does discontinuous involvement of a prostatic needle biopsy core by adenocarcinoma correlate with a large tumor focus at radical prostatectomy?
Samir S Taneja
Page
of 85